US and China-based clinical-stage biopharmaceutical firm Connect Biopharma on Monday announced the completion of a $115-million Series C round of financing led by new investor RA Capital Management, a Boston-based multi-stage investment company.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at email@example.com